These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8689062)

  • 1. [Modified microcolorimeter MKMF-1 for recording of erythrocyte aggregation].
    Plotnikov MB; Aliev OI; Popel' FV
    Klin Lab Diagn; 1995; (3):57-8. PubMed ID: 8689062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the erythrocyte count using a microcolorimeter].
    Storozhuk PG; Storozhuk AP
    Lab Delo; 1990; (8):31-2. PubMed ID: 1705596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of a microcolorimeter in microbiological practice].
    Papanova EV; Soloveĭ VIa; Shmakov IF
    Med Tekh; 1989; (4):47-8. PubMed ID: 2677588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of calorimetry to the evaluation of metabolic data for whole organisms.
    Lamprecht I
    Biochem Soc Trans; 1976; 4(4):565-9. PubMed ID: 793896
    [No Abstract]   [Full Text] [Related]  

  • 5. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors.
    Rotstein R; Landau T; Twig A; Rubinstein A; Koffler M; Justo D; Constantiner D; Zeltser D; Shapira I; Mardi T; Goldin Y; Berliner S
    Atherosclerosis; 2002 Dec; 165(2):343-51. PubMed ID: 12417286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel technique for quantification of erythrocyte aggregation abnormalities in pathophysiological situations.
    Pribush A; Hatzkelson L; Meyerstein D; Meyerstein N
    Clin Hemorheol Microcirc; 2007; 36(2):121-32. PubMed ID: 17325436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modified apparatus for determining erythrocyte aggregation].
    Bichko MV; Korabel'shchikova NI; Rishko NV; Golubka TV
    Lab Delo; 1986; (2):113-4. PubMed ID: 2421054
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal species differences in erythrocyte aggregability.
    Ohta K; Gotoh F; Tomita M; Tanahashi N; Kobari M; Shinohara T; Terayama Y; Mihara B; Takeda H
    Am J Physiol; 1992 Apr; 262(4 Pt 2):H1009-12. PubMed ID: 1566883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modified method of assessing spontaneous erythrocyte aggregation].
    Petrov IuA; Lapotnikov VA
    Klin Lab Diagn; 1994; (6):35. PubMed ID: 7894906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of fibrinogen specific binding in erythrocyte aggregation.
    Lominadze D; Dean WL
    FEBS Lett; 2002 Apr; 517(1-3):41-4. PubMed ID: 12062406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of glycoproteins to fibrinogen-induced aggregation of erythrocytes.
    Maeda N; Seike M; Nakajima T; Izumida Y; Sekiya M; Shiga T
    Biochim Biophys Acta; 1990 Feb; 1022(1):72-8. PubMed ID: 2302404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-chip erythrocyte deformability test under optical pressure.
    Lee WG; Bang H; Yun H; Lee J; Park J; Kim JK; Chung S; Cho K; Chung C; Han DC; Chang JK
    Lab Chip; 2007 Apr; 7(4):516-9. PubMed ID: 17389970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of alcian blue effect on erythrocyte aggregation].
    Bulegenov KE; Balmukhanov BS
    Kardiologiia; 1993; 33(4):42-4. PubMed ID: 7933792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ticlopidine on erythrocyte aggregation in thrombotic disorders.
    Hayakawa M; Kuzuya F
    Angiology; 1991 Sep; 42(9):747-53. PubMed ID: 1928816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A modified method for determining erythrocyte aggregation capacity].
    Liusov VA; Katyshkina NI; Bogoiavlenskaia OV
    Klin Lab Diagn; 1993; (6):37-8. PubMed ID: 8032778
    [No Abstract]   [Full Text] [Related]  

  • 16. Approach to erythrocyte aggregation through erythrocyte sedimentation rate: application of a statistical model in pathology.
    Potron G; Jolly D; Nguyên P; Mailliot JL; Pignon B
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):241-7. PubMed ID: 7971245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes.
    Pfafferott C; Moessmer G; Ehrly AM; Bauersachs RM
    Clin Hemorheol Microcirc; 1999; 21(1):35-43. PubMed ID: 10517486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity.
    Neumann FJ; Tillmanns H; Roebruck P; Zimmermann R; Haupt HM; Kübler W
    Br Heart J; 1989 Dec; 62(6):421-8. PubMed ID: 2690900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sodium fluorescein on erythrocyte aggregation in patients with cerebral microangiopathy.
    Jung F; Kalus U; Wolf S; Pindur G; Kiesewetter H
    Microvasc Res; 1995 Mar; 49(2):246-50. PubMed ID: 7603359
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythrocyte aggregation--studies on the effects of dextran 40 and on the quantitation of aggregation and cohesiveness.
    Engeset J; Stalker AL; Matheson NA
    Bibl Anat; 1967; 9():282-7. PubMed ID: 6029878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.